Multiple Sclerosis (MS) Warning Signs: Silent but Dangerous – Early Detection & Prevention Guide for Young Adults

by

Multiple sclerosis (MS) cases in Turkey have reached alarming levels, with estimates approaching 100,000 patients—nearly half of whom are young adults under 40, according to new data from the Turkish Multiple Sclerosis Society (Türkiye MS Derneği) and Roche Pharmaceuticals. Experts warn the disease’s early symptoms—often subtle and easily dismissed—are leading to delayed diagnoses, allowing the condition to progress silently before patients seek medical help. The urgency of early intervention was highlighted this month at the International Multiple Sclerosis Congress in Istanbul, where neurologists and patient advocates emphasized the need for public awareness campaigns targeting younger demographics.

While MS typically affects individuals in their 20s to 40s, recent studies suggest a rising trend among even younger adults, with some cases now appearing in teenagers. The disease’s insidious onset—where symptoms like fatigue, blurred vision, or mild coordination issues are attributed to stress or overwork—means many patients experience years of undiagnosed progression before receiving a confirmed diagnosis. According to the World Health Organization (WHO), delayed diagnosis can accelerate disability, underscoring the critical window for early treatment.

Turkey’s MS landscape has evolved rapidly in recent years. A 2022 study published in Neurology Turkey estimated the national prevalence at approximately 80,000 cases, but experts now suggest the figure may exceed 100,000 when accounting for underreported cases. The discrepancy stems from diagnostic challenges: MS symptoms can mimic other conditions, and rural areas often lack access to specialized neurologists. “We’re seeing a silent epidemic among young adults who assume their symptoms are temporary,” said Dr. Ayşe Yılmaz, a neurologist at Istanbul’s Istanbul University-Cerrahpaşa Faculty of Medicine. “By the time they’re diagnosed, up to 30% of patients already have significant neurological damage.”

The “Hayat BeniM Sahnem” (My Life, My Stage) initiative, launched in September 2023 by Roche and Türkiye MS Derneği, aims to address this gap through public education and early screening programs. The project, unveiled during the Istanbul congress, includes mobile clinics in underserved regions and digital campaigns targeting universities and workplaces. “Our goal is to reduce the average diagnosis delay from five to two years,” said Roche Turkey’s medical director, Dr. Mehmet Öztürk. “Early intervention with disease-modifying therapies can slow progression by up to 80%.”

Why Are Young Adults Disproportionately Affected?

Genetic and environmental factors appear to be driving the rise in MS among younger populations. Research from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) suggests vitamin D deficiency—a common issue in Turkey’s northern regions—may increase susceptibility, particularly in individuals with a family history of autoimmune diseases. “We’re observing a twofold increase in MS cases among young adults in the last decade,” noted Prof. Levent Özkaya, chair of the Turkish Neurology Association. “This aligns with global trends, but Turkey’s rapid urbanization and changing lifestyles may be accelerating the risk.”

Environmental triggers, including air pollution and sedentary lifestyles, are also under scrutiny. A 2023 study in The Lancet Neurology linked higher MS prevalence in urban areas to fine particulate matter (PM2.5), which is known to trigger inflammatory responses in susceptible individuals. In Istanbul, where PM2.5 levels frequently exceed WHO safety limits, experts caution that prolonged exposure may contribute to the disease’s early onset.

Symptoms Often Go Unnoticed—Here’s What to Watch For

MS presents with a wide range of symptoms, many of which are easily overlooked or attributed to other conditions. The most common early signs include:

  • Fatigue: Persistent exhaustion that doesn’t improve with rest, often described as a “heavy” feeling in limbs.
  • Vision problems: Blurred or double vision, or temporary blindness in one eye (optic neuritis).
  • Numbness or tingling: Often starting in the face, arms, or legs, sometimes triggered by heat.
  • Balance issues: Mild dizziness or coordination problems, such as tripping frequently.
  • Cognitive changes: Memory lapses, difficulty concentrating, or word-finding problems.

“Patients often dismiss these symptoms as stress-related or part of aging,” said Dr. Yılmaz. “But when they appear in clusters—especially if they come and go—it’s a red flag.” The Turkish Multiple Sclerosis Society recommends seeking neurological evaluation if symptoms persist for more than two weeks, particularly if they worsen with heat or physical exertion.

Diagnosis Delays: A Global and Local Crisis

Turkey’s diagnostic landscape reflects broader challenges in MS care. While advanced imaging (MRI) and spinal fluid tests are available in major cities, rural clinics often rely on clinical judgment alone, leading to misdiagnoses. Data from the Turkish Multiple Sclerosis Society shows that 40% of patients wait over two years for a confirmed diagnosis—double the average in Western Europe. “This delay is costing lives,” said Prof. Özkaya. “By the time we intervene, some patients have already developed irreversible disability.”

Internationally, the situation mirrors Turkey’s struggles. In the U.S., the National MS Society reports an average diagnosis delay of three to five years, with young adults facing the longest waits. The WHO attributes these gaps to a combination of low awareness, limited specialist access, and stigma around neurological disorders.

What Happens Next? Early Intervention and Policy Changes

The “Hayat BeniM Sahnem” initiative marks a pivotal moment in Turkey’s MS response, but experts emphasize that sustainable change requires systemic reforms. Key priorities include:

What Happens Next? Early Intervention and Policy Changes
  • Expanded screening programs: Mobile clinics and telemedicine consultations to reach rural populations.
  • Public awareness campaigns: Targeting universities, workplaces, and social media to educate on early symptoms.
  • Insurance coverage reforms: Ensuring all disease-modifying therapies are fully reimbursed under Turkey’s Social Security and General Health Insurance (SGK) system.
  • Research funding: Increasing grants for studies on MS triggers in Turkey’s unique environmental context.

Legislative efforts are also gaining traction. In September 2023, Turkey’s Health Ministry announced a new national MS strategy aimed at reducing diagnostic delays by 50% within five years. The plan includes mandatory MS education in medical schools and partnerships with private hospitals to subsidize advanced diagnostics. “This is a turning point,” said Dr. Öztürk. “For the first time, we have a coordinated approach between government, industry, and patient groups.”

What You Need to Know

  • MS cases in Turkey are approaching 100,000, with young adults under 40 representing nearly half of patients.
  • Early symptoms—fatigue, vision changes, numbness—are often dismissed, leading to delayed diagnoses.
  • Environmental factors like air pollution and vitamin D deficiency may increase risk, particularly in urban areas.
  • The “Hayat BeniM Sahnem” initiative aims to cut diagnosis delays by offering mobile clinics and public education.
  • If symptoms persist for two weeks, seek a neurological evaluation—early treatment can slow progression by up to 80%.

Where to Find Help

If you or someone you know is experiencing MS symptoms, these resources can provide guidance:

The next critical checkpoint for Turkey’s MS response is the 2024 European Multiple Sclerosis Congress (ECTRIMS), where Turkish researchers will present updated prevalence data and early results from the “Hayat BeniM Sahnem” initiative. The Health Ministry has also pledged to release a progress report on the national MS strategy by March 2024, outlining next steps for policy implementation.

If you or a loved one has been affected by MS, share your experiences in the comments below. Your insights can help raise awareness and drive further action. For urgent medical concerns, consult a neurologist or contact your local health authority.

Leave a Comment